Researchers at the Korea Advanced Institute of Science and Technology, led by Professor Kwang-Hyun Cho, have made a groundbreaking discovery in cancer treatment by identifying a molecular “switch” capable of reverting cancer cells to their normal state. Utilizing a digital model of normal cell development, the team observed the oncogenesis process, wherein healthy cells transform into malignant ones. They pinpointed key molecules—MYB, HDAC2, and FOXA2—as “master regulators” whose inhibition induces differentiation, effectively converting colon cancer cells back to normal-like enterocytes. This innovative approach offers a potential alternative to traditional treatments like chemotherapy and radiotherapy, aiming to restore healthy cells rather than destroy cancerous ones.
The study, published in Advanced Science, involved creating a “digital twin” of the gene network to simulate and analyze the critical transition state where cells exhibit both healthy and cancerous traits. By targeting this transitional phase, researchers successfully manipulated molecular pathways to reverse the malignancy of cells. Professor Cho emphasized the significance of this finding, stating, “The fact that cancer cells can be converted back to normal cells is an astonishing phenomenon.” This research not only introduces the concept of reversible cancer therapy but also lays the groundwork for identifying targets to induce cancer cell reversion, potentially leading to less toxic and more effective treatments across various cancer types. Click for More Details
